UNC Charlotte researchers are contributing to pioneering breakthroughs in cancer therapeutics, communicable disease ...

A promising study out of the United Kingdom has partially restored the vision of multiple small children born legally blind.

Financially, Monopar has a cash runway until 2026 but will need additional funds for commercialization efforts. See why I'm ...

Philadelphia’s Spark Therapeutics is going through a “fundamental reorganization” by its owner, Swiss pharmaceutical giant Roche, which has written off the regional biotech leader as a financial loss ...

HC Wainwright restated their buy rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report released on ...

Cash Position: As of December 31, 2024, Fractyl had approximately $67.5 million in cash and cash equivalents. Based on ...

Fat Transport Deficiency Unveiled as Key Factor in Rare Childhood Metabolic CrisesResearchers studying a protein linked to a ...

Launched Niktimvo in the U.S. in late January, in partnership with Incyte. Niktimvo is approved by the U.S. FDA for the treatment of chronic graft-versus-host disease (GVHD) after failure of at least ...

The long-term survival of a patient with neuroblastoma suggests the personalized cancer treatment may work for solid tumors, not just blood cancers.

A research team has elucidated the mechanism behind bacterial cancer therapy using a genetically engineered bacterial strain.

DNA repair proteins act like the body's editors, constantly finding and reversing damage to our genetic code. Researchers ...

A research team led by Prof. Liu Chenli from the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences (CAS) and Prof. Xiao Yichuan from the Shanghai Institute of Nutrition and ...